✦ LIBER ✦

Systematic Review of Colistimethate Sodium Dry Powder and Tobramycin Dry Powder Antibiotics for Pseudomonas Aeruginosa Lung Infection in Cystic Fibrosis

✍ Scribed by Harnan, S.E.; Uttley, L.; Cantrell, A.; Taylor, C.J.; Walshaw, M.; Brownlee, K.; Tappenden, P.

Book ID: 122297057
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 62 KB
Volume: 16
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.08.257

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systematic review of the dry powder inha

Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis

✍ Uttley, L.; Harnan, S.; Cantrell, A.; Taylor, C.; Walshaw, M.; Brownlee, K.; Tap 📂 Article 📅 2013 🏛 European Respiratory Society 🌐 English ⚖ 427 KB

This systematic review evaluated evidence for two dry powder formulations, colistimethate sodium and tobramycin, for the treatment of chronic __Pseudomonas aeruginosa__ in cystic fibrosis, as part of the UK national recommendation process for new technologies. Electronic bibliographic databases were

The Cost-Effectiveness of Dry Powder Ant

The Cost-Effectiveness of Dry Powder Antibiotics for the Treatment of Pseudomonas Aeruginosa in Patients with Cystic Fibrosis

✍ Tappenden, P.; Harnan, S.; Uttley, L.; Mildred, M.; Taylor, C.J.; Brownlee, K.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Carrier-free combination for dry powder

Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis

✍ Pilcer, Gabrielle; De Bueger, Véronique; Traina, Karl; Traore, Hamidou; Sebti, T 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 914 KB

Colistimethate Sodium Dry Powder for Inh

Colistimethate Sodium Dry Powder for Inhalation: A Review of Its Use in the Treatment of ChronicPseudomonas aeruginosaInfection in Patients with Cystic Fibrosis

✍ Conole, Daniel; Keating, Gillian M. 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 441 KB

WS5.5 A randomised, open label phase 3 s

WS5.5 A randomised, open label phase 3 study to evaluate the efficacy and safety of a dry powder formulation of inhaled colistimethate sodium (Colobreathe®) versus tobramycin nebuliser solution (TNS) in cystic fibrosis subjects with chronic Pseudomonas aeruginosa lung infection

✍ M. Goldman; A. Schuster; C. Halliburn; G. Döring 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

In vitro lung delivery of bacteriophages

In vitro lung delivery of bacteriophages KS4-M and ΦKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis

✍ L. Golshahi; K.H. Lynch; J.J. Dennis; W.H. Finlay 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB